RVOT3V79
RVOT3V79
RVOT3V79
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
al. Dosage effects of methylphenidate on the social behavior of adolescents<br />
diagnosed with attention-deficit hyperactivity disorder. Exp Clin<br />
Psychopharmacol. 1998 May;6(2):187-204.<br />
220 Wilens TE, Kratochvil C, Newcorn JH, Gao H. Do children and adolescents<br />
with ADHD respond differently to atomoxetine? J Am Acad<br />
Child Adolesc Psychiatry. 2006 Feb;45(2):149-57.<br />
221 Cox DJ, Humphrey JW, Merkel RL, Penberthy JK, Kovatchev B. Controlled-release<br />
methylphenidate improves attention during on-road<br />
driving by adolescents with attention-deficit/hyperactivity disorder. J<br />
Am Board Fam Pract. 2004 Jul;17(4):235-9.<br />
222 Charach A, Figueroa M, Chen S, Ickowicz A, Schachar R. Stimulant<br />
treatment over 5 years: effects on growth. J Am Acad Child Adolesc<br />
Psychiatry. 2006 Apr;45(4):415-21.<br />
223 MTA Cooperative Group. National Institute of Mental Health Multimodal<br />
Treatment Study of ADHD follow-up: changes in effectiveness<br />
and growth after the end of treatment. Pediatrics. 2004 Apr;113(4):<br />
762-9.<br />
224 Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello<br />
B, et al. Effects of stimulant medication on growth rates across 3 years<br />
in the MTA follow-up. J Am Acad Child Adolesc Psychiatry. 2007<br />
Aug;46(8):1015-27.<br />
225 Spencer TJ, Newcorn JH, Kratochvil CJ, Ruff D, Michelson D, Biederman<br />
J. Effects of atomoxetine on growth after 2-year treatment among<br />
pediatric patients with attention-deficit/hyperactivity disorder. Pediatrics.<br />
2005 Jul;116(1):e74-e80.<br />
226 Spencer TJ, Kratochvil CJ, Sangal RB, Saylor KE, Bailey CE, Dunn<br />
DW, et al. Effects of atomoxetine on growth in children with attentiondeficit/hyperactivity<br />
disorder following up to five years of treatment. J<br />
Child Adolesc Psychopharmacol. 2007 Oct;17(5):689-700.<br />
227 Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant<br />
therapy of attention-deficit/hyperactivity disorder beget later substance<br />
abuse? A meta-analytic review of the literature. Pediatrics. 2003<br />
Jan;111(1):179-85.<br />
228 Wilens TE, Adamson J, Monuteaux MC, Faraone SV, Schillinger M,<br />
Westerberg D, et al. Effect of prior stimulant treatment for attentiondeficit/hyperactivity<br />
disorder on subsequent risk for cigarette smoking<br />
and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc<br />
Med. 2008 Oct;162(10):916-21.<br />
229 Biederman J, Monuteaux MC, Spencer T, Wilens TE, Macpherson<br />
HA, Faraone SV. Stimulant therapy and risk for subsequent substance<br />
use disorders in male adults with ADHD: a naturalistic controlled 10year<br />
follow-up study. Am J Psychiatry. 2008 May;165(5):597-603.<br />
Guía DE PráCtICa CLíNICa SOBrE EL traStOrNO POr DéfICIt DE<br />
atENCIóN CON hIPEraCtIvIDaD (tDah) EN NIñOS y aDOLESCENtES<br />
189
Change language